Home > Industry Insights > Nanoliter Liquid Handling Workstation Industry Research：the revenue CAGR is 7.33% for 2026–2032

Nanoliter Liquid Handling Workstation Industry Research：the revenue CAGR is 7.33% for 2026–2032

Published: 2026-09-04

Page Views: 242

Industry: Machinery & Equipment

Nanoliter Liquid Handling Workstation

Nanoliter Liquid Handling Workstation Market Summary

A nanoliter liquid handling workstation refers to an automated liquid handling system designed for high-throughput workflows such as microplate-based experiments. Its core capability is to deliver stable and repeatable nanoliter-scale (nL) dispensing/transfer to support high-density screening, micro-volume reaction setup, and sample preparation. In the market, nanoliter performance is most commonly achieved via non-contact dispensing, which can be broadly grouped into two mainstream technology routes: Ultrasonic Technology (acoustic/ultrasonic droplet transfer) and Inkjet Technology (jetting / inkjet-like dispensing). Representative products include Beckman Coulter Echo (Ultrasonic) and Dispendix I.DOT and Revvity FlexDrop™ Plus (Inkjet).

Beyond non-contact routes, a limited number of systems can also achieve nanoliter performance through contact pipetting (tip/needle-based), though these are less common. For example, SPT Labtech mosquito LV genomics can reach a minimum aspirate volume of 25 nL and is therefore included in this study’s definition of nanoliter liquid handling workstations. To ensure comparability and reflect genuine nanoliter capability, this study typically uses a minimum achievable volume of ≤50 nL as the benchmark threshold. Some products only specify a minimum volume in the range of 100–500 nL (i.e., 0.1–0.5 µL); these systems are closer to micro-volume, microliter-level performance and, based on interview feedback, are generally not benchmarked alongside typical nanoliter workstations. In practice, some suppliers only disclose the lower limit in microliters (e.g., 0.2 µL, 0.35 µL) rather than explicitly stating nL; such systems are treated as microliter-level. In addition, some manufacturers may show several-hundred-nanoliter specifications on certain product pages, yet still position these systems as microliter-level in interviews; for example, Agilent has products with minimum volumes in the several-hundred-nanoliter range, but interview feedback indicates the company categorizes its offering as microliter-class rather than nanoliter-class.

Market Overview

From a global market perspective, nanoliter liquid handling workstations generated revenue of USD 86.78 million in 2025 and are projected to reach USD 144.48 million by 2032. The revenue CAGR is 7.33% for 2026–2032 and 10.03% for 2021–2025. In unit terms, shipments increase from 366 units in 2025 to 673 units in 2032, indicating that the segment remains in an expansion phase driven by broader adoption of miniaturized workflows; as the installed base grows, the growth rate transitions from the faster 2021–2025 period to a more steady trajectory in 2026–2032. Key demand drivers include continued miniaturization in drug discovery and screening, genomics sample preparation and reaction setup, and the wider penetration of laboratory automation and standardization across pharmaceutical and research platforms. In parallel, rising expectations for reproducibility and traceability are accelerating product upgrades in droplet verification, process monitoring, and data logging.

The competitive structure is highly concentrated and characterized by a limited number of commercially proven suppliers, supported by long customer validation cycles and high switching costs. In 2025, the global top three manufacturers account for 84.07% of total sales, reflecting strong barriers built on proprietary dispensing technologies, application know-how, installed base depth, and global channel plus service coverage. Market share movements are typically driven by workflow penetration and platform upgrades rather than price-led competition. As a result, competition is better described as workflow and validation capability competition, including method transfer efficiency, cross-site consistency, completeness of quality and metrology documentation, and compatibility with robotic lines and end-to-end automation.

By technology type (revenue basis), ultrasonic technology contributes USD 50.07 million in 2025, representing 57.70% of the market; inkjet technology contributes USD 27.38 million, or 31.55%; and other technologies contribute USD 9.33 million, or 10.75%. In terms of growth, inkjet technology posts a 2026–2032 revenue CAGR of 8.73%, above ultrasonic technology at 6.82% and other technologies at 5.82%, suggesting stronger expansion elasticity for non-contact high-speed dispensing across a wider set of use cases. Ultrasonic platforms remain dominant in core scenarios that require extremely low volumes and high repeatability. Overall, product evolution is shifting from simply achieving smaller volumes toward engineering performance that emphasizes lower dead volume, stronger in-process verification and traceability, easier integration, and lower deployment barriers.

By application (revenue basis), biopharmaceutical companies are the largest demand source in 2025 with USD 50.00 million, accounting for 57.62% of total revenue. Universities and research institutes contribute USD 17.78 million (20.49%), medical institutions USD 12.03 million (13.86%), government agencies USD 5.79 million (6.67%), and others USD 1.18 million (1.36%). For 2026–2032, medical institutions show the highest revenue CAGR at 10.07%, followed by biopharmaceutical companies at 8.08%, while universities and research institutes grow at 3.17%. This indicates that incremental demand is increasingly driven by more translational and clinically adjacent workflows and industrialized R&D settings, while academia expands more steadily.

By region (revenue basis), the Americas account for USD 39.61 million in 2025 (45.64%), Europe USD 28.44 million (32.77%), APAC USD 15.05 million (17.34%), and the Middle East & Africa USD 3.68 million (4.24%). In growth terms, APAC records a 2026–2032 revenue CAGR of 9.17%, consistent with accelerating R&D investment and lab automation build-out. The Middle East & Africa shows a 9.53% CAGR largely due to a small base, reflecting project-driven ramp-up from a low starting point rather than a large absolute scale approaching mature markets. The Americas (7.33%) and Europe (5.96%) reflect continued upgrades and expansion within established installed bases, with demand skewing toward higher-end configurations, system integration, and long-term service support.

Overall, the segment is expected to follow a path of high concentration, application expansion, and engineering-driven upgrades through 2026–2032. Leading suppliers are positioned to capture most of the incremental growth, with market shares changing only modestly. Innovation will continue to center on lower dead volume, verification and traceability, automation compatibility, and simplified deployment. In summary, this is a high-barrier niche within life science automation, with growth underpinned by the structural trend toward miniaturized workflows and deeper laboratory automation adoption.

Figure00002. Global Nanoliter Liquid Handling Workstation Market Size (US$ Million), 2025 vs 2032